The treatment of dementia is dependent on the etiology and stage of the condition.[6,34] Cholinesterase inhibitors, memantine, and antiamyloid (Aβ) immunomodulators are utilized to moderately slow cognitive decline in patients with Alzheimer disease or mild dementia.[35] Nonpharmacological interventions, such as identifying triggers and implementing personalized behavioral therapies, are preferred for managing psychiatric and behavioral symptoms associated with dementia. This evidence concerns the gene BCHE and Mental deterioration.